Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity Terminated Phase 2 Trials for Dexamethasone (DB01234)

IndicationStatusPhase
DBCOND0028768 (Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00895245Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation TherapySupportive Care